[1] |
XIE Mengqing, CHU Xiangling, ZHOU Juan, SU Chunxia.
The advances in immunotherapy biomarkers of small cell lung cancer
[J]. China Oncology, 2021, 31(7): 635-639.
|
[2] |
ZHENG Peiming , LI Junmeng , ZHANG Peng , GAO Lan .
Exosomal transfer of macrophage-derived miR-223 confers oxaliplatin resistance in gastric cancer
[J]. China Oncology, 2021, 31(5): 368-378.
|
[3] |
LI Ruixiao , TANG Qisheng , MA Shanjin , ZHANG Bo , LI Xuelian , ZHANG Zhiming .
NDRG2 increases bladder cancer cell sensitivity to cisplatin by inhibiting Bcl-2 expression
[J]. China Oncology, 2021, 31(4): 263-267.
|
[4] |
WANG Ming, CAO Hui.
Recent advances in drug therapy for advanced gastrointestinal stromal tumor
[J]. China Oncology, 2021, 31(2): 90-99.
|
[5] |
LI Zhijun, XU Binghe.
Research progress of resistance to aromatase inhibitor therapy in breast cancer
[J]. China Oncology, 2021, 31(2): 81-89.
|
[6] |
The Society of Gynecological Cancer of China Anti-Cancer Association, Chinese Society of Pathology of the Chinese Medical Association, National Pathology Quality Control Center.
The Chinese Expert Consensus Recommendations on Molecular Testing in Endometrial Cancer (2021 edition)
[J]. China Oncology, 2021, 31(11): 1126-1144.
|
[7] |
YE Xingming , WANG Lin , JIA Jing , WU Xiufeng , CHEN Ying .
miR-375 targeting YAP1 modulates trastuzumab resistance through epithelial-mesenchymal transition in breast cancer cells
[J]. China Oncology, 2021, 31(1): 27-34.
|
[8] |
GUO Li, YANG Shun’e, LI Xun.
Association between ABCG2 gene polymorphism and breast cancer recurrence in Xinjiang
[J]. China Oncology, 2020, 30(5): 340-346.
|
[9] |
CHENG Qi, YI Xiaofang.
Research progress on ferroptosis in drug resistance of tumor
[J]. China Oncology, 2020, 30(2): 148-153.
|
[10] |
ZHU Xiaodong, CHEN Siyuan.
Combination therapy of immune checkpoint inhibitors: from rationale to practice
[J]. China Oncology, 2020, 30(12): 969-976.
|
[11] |
ZHOU Jian, ZHANG Chaoyang, SUN Wei, YANG Jun, ZHANG Zhichao, QI Xiaohong.
Effects of miR-503 targeting TLR4 on drug resistance to docetaxel in prostate cancer
[J]. China Oncology, 2020, 30(11): 858-864.
|
[12] |
HONG Shaodong, ZHANG Li.
Recent advances and prospect in targeted therapy for lung cancer
[J]. China Oncology, 2020, 30(10): 733-743.
|
[13] |
YANG Yu , ZHOU Huandi , XUE Xiaoying , ZHANG Ge , HAN Xuetao , TIAN Zhesen , LI Yuehong .
The role and mechanism of NRAGE in radioresistance of human esophageal cancer cells
[J]. China Oncology, 2020, 30(1): 41-48.
|
[14] |
SUN Jianda, XIONG Jun, ZHANG Hanxiong, CHEN Yibiao.
Prognostic values of hematological biomarkers in locoregionally advanced nasopharyngeal carcinoma
[J]. China Oncology, 2019, 29(7): 528-534.
|
[15] |
ZHENG Xiaocui, WANG Xipeng.
Progress of single-cell sequencing in solid tumors
[J]. China Oncology, 2019, 29(7): 535-539.
|